# Ana Marcu

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ana-marcu/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,736 |
| Field | Immunotherapy and Immune Responses |
| h-index | 25 |
| i10-index | 31 |
| Last Known Institution | Abterra Biosciences (United States) |
| OpenAlex ID | https://openalex.org/A5012388687 |
| ORCID iD | https://orcid.org/0000-0003-0808-8097 |
| Works | 56 |

## Researcher papers

- [HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy](https://scholariq.org/papers/hla-ligand-atlas-a-benign-reference-of-hla-presented-peptides-to-improve-t-cell/)

## Researcher topics

- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [vaccines and immunoinformatics approaches](https://scholariq.org/topics/vaccines-and-immunoinformatics-approaches-2/)
- [Metabolomics and Mass Spectrometry Studies](https://scholariq.org/topics/metabolomics-and-mass-spectrometry-studies/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)

## Researcher university

- [Abterra Biosciences (United States)](https://scholariq.org/institutions/abterra-biosciences-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.